author-photo

Suyapa A. Bejarano

3

Papers

4

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Confirmed tumor response by molecular subtype in patients with metastatic breast cancer: Sub-analysis from a phase 3 clinical study comparing oral paclitaxel and encequidar to IV paclitaxel.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
KX-ORAX-001: An open label, randomized, multicenter, phase III registrational study to determine the safety, tolerability, and tumor response of oraxol (HM30181A + oral paclitaxel) and its comparability to IV paclitaxel in patients with metastatic breast cancer (MBC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)